|
Hematology and Hemostasis |
922 |
Leveraging Whole Genome Sequencing data in TOPMed to refine prior GWAS loci and further identify new/novel loci that determine platelet aggregation. |
Rasika Mathias |
|
Hematology and Hemostasis |
14911 |
(Breakout) Integrative analysis of multi-omics data for platelet aggregation in GeneSTAR |
Rasika Mathias |
|
Hematology and Hemostasis |
12200 |
(Revised) Clonal hematopoiesis of indeterminate potential, circulating proteome, and coronary artery disease |
Zhi Yu |
|
Hematology and Hemostasis |
18264 |
(Revised) Demystifying Mechanistic Pathways for Coronary Artery Disease with Biologically Informed Neural Networks |
Zhi Yu |
|
Hematology and Hemostasis |
12218 |
(Revised) Interaction analysis for clonal hematopoiesis on coronary artery disease. |
Tetsushi Nakao |
|
Hematology and Hemostasis |
12031 |
(Revised) Investigating the effect of germ-line structural variants on blood cell traits: the TOPMed whole genome sequencing project |
Paul Auer |
|
Hematology and Hemostasis |
14151 |
(Revised) Sickle cell trait and the Risk of Severe COVID-19 in individuals of African ancestry |
Alex Reiner |
|
Hematology and Hemostasis |
928 |
A family based approach leveraging WGS data to study telomere length in GeneSTAR African Americans and European Americans. |
Rasika Mathias |
|
Hematology and Hemostasis |
12435 |
A whole-genome sequencing based large-scale meta-analysis of blood cell traits |
Paul Auer |
|
Hematology and Hemostasis |
14743 |
ABO Blood Group and the Risk of Severe COVID-19 |
Debora Kamin Mukaz |
